Skip to main content
Premium Trial:

Request an Annual Quote

If Only It Were So Simple for Us to Resist Them

It's a good thing the genomics community has been so involved in studies of tuberculosis and Yersinia pestis. Recent news reports indicate that while overall rates of TB are hitting a plateau, a drug-resistant strain of the disease is emerging. Meanwhile, scientists have found a multiple drug-resistant form of the plague as well. Looks like we'll need every tool in the arsenal to keep up.


The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.